Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
The new virus SARS-CoV-2 is savagely spreading out over the world. The biologic studies show that the target receptor for the virus might be angiotensin-converting enzyme 2 (ACE2). This peptide is responsible for converting angiotensin II (Ang II), which is a profoundly active peptide, into Ang 1-7...
Main Authors: | Seyed-Mohammad Ghahestani, Javad Mahmoudi, Sakineh Hajebrahimi, Amir-Babak Sioofy-Khojine, Hanieh Salehi-Pourmehr, Fatemeh Sadeghi-Ghyassi, Hadi Mostafaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2020-05-01
|
Series: | Iranian Journal of Allergy, Asthma and Immunology |
Subjects: | |
Online Access: | https://ijaai.tums.ac.ir/index.php/ijaai/article/view/2785 |
Similar Items
-
Bradykinin and its role in osteoarthritis
by: L. De Falco, et al.
Published: (2013-07-01) -
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B2 Receptor Antagonist
by: Anne Lesage, et al.
Published: (2020-06-01) -
Cardiovascular and myotropic actions of bradykinin and angiotensin II in the little skate, Leucoraja erinacea
by: Dasiewicz, Patricia J
Published: (2011) -
Cardiovascular and myotropic actions of bradykinin and angiotensin II in the little skate, Leucoraja erinacea
by: Dasiewicz, Patricia J
Published: (2011) -
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists
by: Xavier eCharest-Morin, et al.
Published: (2014-03-01)